Wealthstreet Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Wealthstreet Investment Advisors's PFE Position: Q1 2022 in Review
Wealthstreet Investment Advisors held its Pfizer (PFE) position steady in Q1 2022 at 113 shares worth $6K. The position accounts for 0.16% of the portfolio, ranked #64.
Wealthstreet Investment Advisors first reported a position in PFE in Q4 2017 and has held it in 18 quarters since. The position peaked at $6.49M in Q3 2018. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- Wealthstreet Investment Advisors held 113 shares of Pfizer worth $6K as of Q1 2022.
- Wealthstreet Investment Advisors left its Pfizer share count unchanged in Q1 2022.
- Pfizer made up 0.16% of Wealthstreet Investment Advisors's portfolio in Q1 2022, its #64 holding.
- Wealthstreet Investment Advisors first reported a position in Pfizer in Q4 2017 and has held it in 18 quarters since.
- Wealthstreet Investment Advisors's Pfizer position peaked at $6.49M in Q3 2018.
- 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on Wealthstreet Investment Advisors's 13F filing for Q1 2022, filed 25 Apr 2022.